Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 16, 2010
The sex ratio in amyotrophic lateral sclerosis: A population based studyZita R Manjaly, Kirsten M Scott, Kumar Abhinav, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 1, 2016
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosisAlexander J McGeachan, Esther V Hobson, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 8, 2013
Management of sialorrhoea in motor neuron disease: a survey of current UK practiceEsther V Hobson, Alexander McGeachan, Ammar Al-Chalabi, et al.
American Journal of Human Genetics|February 26, 2013
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK populationJon Beck, Mark Poulter, Davina Hensman, et al.
Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Brain : a Journal of Neurology|April 19, 2007
Large-scale pathways-based association study in amyotrophic lateral sclerosisDalia Kasperaviciute, Mike E Weale, Kevin V Shianna, et al.
Neurobiology of Aging|September 3, 2014
Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansionPietro Fratta, James M Polke, Jia Newcombe, et al.
The Lancet. Neurology|October 11, 2014
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling studyAmmar Al-Chalabi, Andrea Calvo, Adriano Chio, et al.
Neurobiology of Aging|September 20, 2011
Chromosome 9 ALS and FTD locus is probably derived from a single founderKin Mok, Bryan J Traynor, Jennifer Schymick, et al.
Lancet (London, England)|May 12, 2024
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UKRebecca L Gould, Christopher J McDermott, Benjamin J Thompson, et al.
Pageof 13